Macular Retinal Vitreal Assoc Glendale, CA - 91202

Macular Retinal Vitreal Assoc is categorized under Doctors in Glendale, CA and active since 2008.

Macular Retinal Vitreal Assoc was established in 2008, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Marta A Recasens at the company’s single location by writing to 1025 North Brand Boulevard # 200, Glendale, California CA 91202 or by phoning (818) 552-2140. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Macular Retinal Vitreal Assoc
Contact Person: Marta A Recasens
Address: 1025 North Brand Boulevard # 200, Glendale, California 91202
Phone Number: (818) 552-2140
Website Address: macretvit.net
Annual Revenue (USD): $500.000 to $999.999
Founded: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Macular Retinal Vitreal Assoc was started in 2008 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Marta A Recasens for inquiries that concern Macular Retinal Vitreal Assoc by calling the company number (818) 552-2140, as your correspondence is most welcome. Additionally, the physical location of the single location of Macular Retinal Vitreal Assoc can be found at the coordinates 34.16097,-118.25512 as well as the street address 1025 North Brand Boulevard # 200 in Glendale, California 91202.

For its online presence, you may visit Macular Retinal Vitreal Assoc’s website at macretvit.net and engage with its social media outlets through on Twitter and on Facebook.